Fibroblast growth factor 21 (FGF21) is an endogenous liver-secreted hormone that has therapeutic potential for treating obesity, type 2 diabetes, and MASLD [190]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.